# Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia

> **NCT00503581** · PHASE2 · TERMINATED · sponsor: **Gynecologic Oncology Group** · enrollment: 9 (actual)

## Conditions studied

- High Grade Squamous Intraepithelial Neoplasia
- Stage 0 Uterine Corpus Cancer

## Interventions

- **PROCEDURE:** Biopsy
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Megestrol Acetate
- **OTHER:** Pharmacological Study
- **OTHER:** Quality-of-Life Assessment
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT00503581
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2012-07
- **Final completion:** —
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00503581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00503581, "Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00503581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*